Allarity Therapeutics — Oncology Venture — Fact Sheet (April 2019)

2 slides from Allarity Therapeutics's fact sheet, April 2019

Slide 1: Precision medicine, business highlights, financial summary and organization
PRECISION MEDICINE FINANCIAL SUMMARY ORG. STRUCTURE Oncology Venture utilizes a technology that al- Buhl Jensen founded Oncology Venture AB (OV) lopment phase.Thereby, efficiency can be increa- Track, Match and Treat: Planned clinical studies: cer drugs for a given indication to give guidance Summar
Slide 2: Invitation to subscribe for rights: funding of research and development
INVITATION TO SUBSCRIBE FOR RIGHTS FUNDING OF RESEARCH AND DEVELOPMENT The offer in summary What the new financial recourses will be used for. Subscription period: 17 April – 2 May 2019. A large part of Oncology Venture’s capital is used for research Issue price: SEK 4.00 per unit. and development.